The Technical Analyst
Vallon Pharmaceuticals [VLON]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Vallon Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals
-13.04% $0.400
America/New_York / 4 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5.39 mill |
| EPS: | -15.36 |
| P/E: | -0.0300 |
| Earnings Date: | Jul 26, 2023 |
| SharesOutstanding: | 13.48 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2024-03-15 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0300 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -0.0300 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.330 - 0.470 ( +/- 17.50%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-09-22 | Kelly Leanne | Buy | 83 333 | Stock Option (Right to Buy) |
| 2023-08-10 | Szekeres David Leslie | Buy | 34 483 | Stock Option (Right to Buy) |
| 2023-08-10 | Simpson Camilla V | Buy | 34 483 | Stock Option (Right to Buy) |
| 2023-08-10 | Rongen Roelof | Buy | 34 483 | Stock Option (Right to Buy) |
| 2023-08-10 | Baker David Charles | Buy | 34 483 | Stock Option (Right to Buy) |
| INSIDER POWER |
|---|
| 96.44 |
| Last 43 transactions |
| Buy: 1 581 385 | Sell: 149 455 |
Forecast:
01:40 - $0.477
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.400 (-13.04% ) |
| Volume | 1.113 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VLON
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VLON
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Latest Press Releases
2023-01-11 08:45:00 - Press Release
Vallon Pharmaceuticals And Gri Bio To Present At The Virtual Investor 2023 Companies To Watch Event
Live video webcast on tuesday, january 17 , 2023 at 1:00 pm et
2022-01-20 08:35:00 - Press Release
Vallon Pharmaceuticals To Present At The Virtual Investor 2022 Top Picks Conference
– liv e video webcast presentation on tuesday, january 25 th at 9:00 am et
2022-01-04 08:05:00 - Press Release
Vallon Pharmaceuticals To Present At The H.c. Wainwright Bioconnect Conference
Philadelphia, pa, jan. 04, 2022 (globe newswire) -- vallon pharmaceuticals, inc. (nasdaq: vlon), (“vallon” or the “company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (cns) disorders, announced today that david baker, president & chief executive officer of vallon will present at the virtual h.c. wainwright bioconnect conference, taking place january 10-13, 2022.
2021-11-11 08:05:00 - Press Release
Vallon Pharmaceuticals To Present At The Virtual Investor Roundtable Event
- live moderated video webcast discussion among members of management and adhd and a buse e xpert, stephen v. faraone, ph.d., on t hurs day, november 18 th at 3 :00 p m et
2021-11-10 08:35:00 - Press Release
Vallon Pharmaceuticals To Present At The H.c. Wainwright 7th Annual Israel Virtual Conference
- live video webcast presentation on monday, november 15 th at 8:30 am et
Latest News
2023-03-06 15:07:51 - PennyStocks
Best Penny Stocks For 2023? 3 To Watch In March
2023-02-14 06:00:00 - PennyStocks
How to Analyze Penny Stocks for Profits
Use these tips for analyzing penny stocks in 2023 The post How to Analyze Penny Stocks for Profits appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-13 08:22:51 - InvestorPlace
Why Is Vallon Pharmaceuticals (VLON) Stock Up 38% Today
Vallon Pharmaceuticals (NASDAQ: VLON ) stock is rising higher on Monday despite a lack of news from the clinical-stage biopharmaceutical company. Instead, it looks like heavy trading is behind today's gains.
2023-02-11 11:00:00 - PennyStocks
The Benefits of Investing in Penny Stocks in the Long Term
Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-10 10:45:23 - PennyStocks
3 Penny Stocks To Watch After Big News In February 2023
Penny stocks to watch with news this week. The post 3 Penny Stocks To Watch After Big News In February 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-01-11 08:45:00 - GlobeNewsWire
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
2022-12-15 06:00:00 - PennyStocks
Making Profits With Penny Stocks, Beginners Guide
Check out these tips for making money with penny stocks The post Making Profits With Penny Stocks, Beginners Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-12-14 10:45:53 - InvestorPlace
Why Is Vallon Pharmaceuticals (VLON) Stock Up 95% Today?
Vallon Pharmaceuticals (NASDAQ: VLON ) stock is rocketing higher on Wednesday as investors react to news of a merger agreement with GRI Bio. According to a press release, GRI Bio will combine with a subsidiary of Vallon Pharmaceuticals.
2022-10-19 11:50:00 - PennyStocks
Best Penny Stocks To Buy Now? 4 Low Float Stocks To Watch This Week
2022-07-03 11:30:00 - PennyStocks
How to Make a Penny Stocks Watchlist in July 2022
Consider these tips for making a penny stocks watchlist right now The post How to Make a Penny Stocks Watchlist in July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.